Biotech ETFs Pop After Novartis Acquires Medicines Co.

Biotechnology ETFs led the charge on Monday after Novartis AG (NYSE: NVG) agreed to buy Medicine Co. (NasdaqGS: MDCO) as the Swiss multinational pharmaceutical company moves to expand its treatment for complex conditions. Among the best performing non-leveraged ETFs of Monday, the SPDR S&P...